934664-41-2 (1-BOC-3-亚甲基氮杂环丁烷,tert-butyl 3-methylideneazetidine-1-carboxylate)

CAS号:
934664-41-2
中文名称:
1-BOC-3-亚甲基氮杂环丁烷
英文名称:
tert-butyl 3-methylideneazetidine-1-carboxylate
分子式:
C9H15NO2
分子量:
169.220902681351

1-BOC-3-亚甲基氮杂环丁烷(934664-41-2)名称与标识符

名称

中文别名:
1-BOC-3-亚甲基氮杂环丁烷;3-甲基氮杂环丁烷-1-羧酸叔丁酯;3-亚甲基氮杂丁烷-1-羧酸叔丁酯;3-亚甲基吖丁啶-1-羧酸叔丁酯;
英文别名:
tert-Butyl 3-methyleneazetidine-1-carboxylate;3-Methylene-azetidine-1-carboxylic acid tert-butyl ester;1-Boc-3-methylideneazetid...;tert-butyl 3-methylideneazetidine-1-carboxylate;1-Boc-3-methylideneazetidine;1,1-DIMETHYLETHYL 3-METHYLIDENEAZETIDINE-1-CARBOXYLATE;MECAHFSQQZQZOI-UHFFFAOYSA-N;5860AC;PB19228;AM804576;AB1011612;AB0050474;tert-butyl 3-methylene-azetidine-1-carboxylate;3-Methyleneaze;J-524559;SY046612;DB-371887;CS-W022997;EN300-155692;DTXSID70717214;AKOS006316676;MFCD12031229;B6011;ALBB-031201;SCHEMBL1488353;1-Boc-3-methyleneazetidine;SS-4888;934664-41-2;tert-Butyl3-methyleneazetidine-1-carboxylate;

标识符

MDL:
MFCD12031229
InChIKey:
MECAHFSQQZQZOI-UHFFFAOYSA-N
Inchi:
1S/C9H15NO2/c1-7-5-10(6-7)8(11)12-9(2,3)4/h1,5-6H2,2-4H3
SMILES:
O=C(N1CC(=C)C1)OC(C)(C)C

1-BOC-3-亚甲基氮杂环丁烷(934664-41-2)物化性质

实验特性

  • 沸点 : 214.8±29.0°C at 760 mmHg

计算特性

  • 精确分子量 : 169.110278721g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 2
  • 可旋转化学键数量 : 2
  • 同位素质量 : 169.110278721g/mol
  • 重原子数量 : 12
  • 复杂度 : 207
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1
  • 拓扑分子极性表面积 : 29.5

1-BOC-3-亚甲基氮杂环丁烷(934664-41-2)安全信息

1-BOC-3-亚甲基氮杂环丁烷(934664-41-2)推荐厂家 更多厂家(25)

1-BOC-3-亚甲基氮杂环丁烷(934664-41-2)合成路线

合成路线:1 步
反应条件:
参考文献:
Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973)
Rice, Kenneth D.; Aay, Naing; Anand, Neel K.; Blazey, Charles M.; Bowles, Owen J.; et al, ACS Medicinal Chemistry Letters, 2012, 3(5), 416-421
合成路线:1 步
反应条件:
参考文献:
Preparation of N-acylazetidine MEK inhibitors and 4-aryl-2-aminopyrimidine or 4-aryl-2-aminoalkylpyrimidine JAK-2 inhibitors and their combinations useful for treating neoplasm
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of azetidines as MEK kinase inhibitors for the treatment of proliferative diseases, especially cancer
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Pleuromutilin derivative and application as antibacterial agents
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of sp3-Enriched β-Fluoro Sulfonyl Chlorides
Gurbanov, Rustam; Sokolov, Andriy; Golovach, Sergey; Melnykov, Kostiantyn; Dobrydnev, Alexey V. ; et al, Synthesis, 2021, 53(10), 1771-1784
合成路线:1 步
反应条件:
参考文献:
Spiroheterocyclic compounds as mGlu5 antagonists and their preparation and use for the treatment of diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Site-Specific Alkene Hydromethylation via Protonolysis of Titanacyclobutanes
Law, James A.; Bartfield, Noah M.; Frederich, James H., Angewandte Chemie, 2021, 60(26), 14360-14364
合成路线:1 步
反应条件:
参考文献:
Preparation of azaindazole compounds as inhibitors of T790M containing EGFR mutants
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Branch-Selective Addition of Unactivated Olefins into Imines and Aldehydes
Matos, Jeishla L. M.; Vasquez-Cespedes, Suhelen; Gu, Jieyu; Oguma, Takuya; Shenvi, Ryan A., Journal of the American Chemical Society, 2018, 140(49), 16976-16981
合成路线:1 步
反应条件:
参考文献:
Branch-selective addition of unactivated olefins into imines and aldehydes
Matos, Jeishla L. M.; Vasquez-Cespedes, Suhelen; Gu, Jieyu; Oguma, Takuya; Shenvi, Ryan A., ChemRxiv, 2018, 1, 1-7
合成路线:1 步
反应条件:
参考文献:
Selective octahydrocyclopenta[c]pyrroles as negative modulators of NR2B and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of triazolopyridine derivatives for use as PIM kinase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Oxidative Cascade Reaction of N-Aryl-3-alkylideneazetidines and Carboxylic Acids: Access to Fused Pyridines
Cai, Wangshui; Wang, Shuang; Jalani, Hitesh B. ; Wu, Junxian; Lu, Hongjian ; et al, Organic Letters, 2018, 20(13), 3833-3837
合成路线:1 步
反应条件:
参考文献:
Preparation of spiroisoxazoline compounds having a potentiating effect on the activity of ethionamide and their use for treating mycobacterial infections such as tuberculosis and leprosy
, France, , ,
合成路线:1 步
反应条件:
参考文献:
Hydrophilic azaspiroalkenes as robust bioorthogonal reporters
An, Peng; Wu, Hsuan-Yi; Lewandowski, Tracey M.; Lin, Qing, Chemical Communications (Cambridge, 2018, 54(99), 14005-14008
合成路线:1 步
反应条件:
参考文献:
Asymmetric Catalytic Ring-Expansion of 3-Methyleneazetidines with α-Diazo Pyrazoamides towards Proline-Derivatives
Wang, Kaixuan ; Yang, Longqing; Li, Yi; Li, Hongye; Liu, Zhili; et al, Angewandte Chemie, 2023, 62(32),
合成路线:1 步
反应条件:
参考文献:
Identification of false positives in "HTS hits to lead": The application of Bayesian models in HTS triage to rapidly deliver a series of selective TRPV4 antagonists
Skerratt, Sarah E.; Mills, James E. J.; Mistry, Jayesh, MedChemComm, 2013, 4(1), 244-251